Cargando…
Geranylgeraniol prevents zoledronic acid-mediated reduction of viable mesenchymal stem cells via induction of Rho-dependent YAP activation
Long-term use of zoledronic acid (ZA) increases the risk of medication-related osteonecrosis of the jaw (MRONJ). This may be attributed to ZA-mediated reduction of viable mesenchymal stem cells (MSCs). ZA inhibits protein geranylgeranylation, thus suppressing cell viability and proliferation. Gerany...
Autores principales: | Singhatanadgit, Weerachai, Hankamolsiri, Weerawan, Janvikul, Wanida |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8187992/ https://www.ncbi.nlm.nih.gov/pubmed/34113452 http://dx.doi.org/10.1098/rsos.202066 |
Ejemplares similares
-
IFNγ-primed periodontal ligament cells regulate T-cell responses via IFNγ-inducible mediators and ICAM-1-mediated direct cell contact
por: Singhatanadgit, Weerachai, et al.
Publicado: (2022) -
The prenyltransferase UBIAD1 is the target of geranylgeraniol in degradation of HMG CoA reductase
por: Schumacher, Marc M, et al.
Publicado: (2015) -
Antibacterial and osteogenic activities of clindamycin-releasing mesoporous silica/carboxymethyl chitosan composite hydrogels
por: Sungkhaphan, Piyarat, et al.
Publicado: (2021) -
Dual-Functional
Drug Delivery System for Bisphosphonate-Related
Osteonecrosis Prevention and Its Bioinspired Releasing Model and In
Vitro Assessment
por: Sungkhaphan, Piyarat, et al.
Publicado: (2023) -
Geranylgeraniol Restores Zoledronic Acid-Induced Efferocytosis Inhibition in Bisphosphonate-Related Osteonecrosis of the Jaw
por: Chen, Xin, et al.
Publicado: (2021)